Skip to main content
Premium Trial:

Request an Annual Quote

BioSkryb Genomics Inks Deal With Research Instruments to Bring Single-Cell Tools to Southeast Asia

NEW YORK – Single-cell technology company BioSkryb Genomics said on Wednesday that it has entered a distribution agreement with life science research products distributor Research Instruments to bring the company’s single-cell amplification products to Southeast Asia.

Financial details of the deal were not disclosed.

Under the agreement, Research Instruments, which is part of Everlife Asia, will distribute BioSkryb’s ResolveDNA and ResolveOme single-cell amplification tools in Singapore and other parts of Southeast Asia.

"Expanding into these critical markets will support scientific breakthroughs in research, diagnostics, and treatments through increased access to the unmatched resolution of our single-cell multiomics platforms," BioSkryb CEO Suresh Pisharody said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.